Alnylam Pharmaceuticals Inc (ALNY)
146.05
+0.21
(+0.14%)
USD |
NASDAQ |
Apr 23, 16:00
146.05
0.00 (0.00%)
After-Hours: 20:00
Alnylam Pharmaceuticals Cash from Investing (TTM): -336.35M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -336.35M |
| September 30, 2023 | -235.60M |
| June 30, 2023 | 89.05M |
| March 31, 2023 | 240.56M |
| December 31, 2022 | 169.35M |
| September 30, 2022 | -104.14M |
| June 30, 2022 | -506.30M |
| March 31, 2022 | -492.07M |
| December 31, 2021 | -273.30M |
| September 30, 2021 | 42.22M |
| June 30, 2021 | 120.40M |
| March 31, 2021 | -477.85M |
| December 31, 2020 | -435.52M |
| September 30, 2020 | -558.48M |
| June 30, 2020 | -558.47M |
| March 31, 2020 | -406.64M |
| December 31, 2019 | -417.68M |
| September 30, 2019 | 52.14M |
| June 30, 2019 | 158.39M |
| March 31, 2019 | 510.41M |
| December 31, 2018 | 272.94M |
| September 30, 2018 | -136.61M |
| June 30, 2018 | -369.96M |
| March 31, 2018 | -500.25M |
| December 31, 2017 | -290.36M |
| Date | Value |
|---|---|
| September 30, 2017 | -29.38M |
| June 30, 2017 | 76.39M |
| March 31, 2017 | 99.73M |
| December 31, 2016 | 142.59M |
| September 30, 2016 | 120.47M |
| June 30, 2016 | 200.55M |
| March 31, 2016 | 137.95M |
| December 31, 2015 | -321.32M |
| September 30, 2015 | -378.16M |
| June 30, 2015 | -388.92M |
| March 31, 2015 | -510.36M |
| December 31, 2014 | -548.81M |
| September 30, 2014 | -514.20M |
| June 30, 2014 | -554.61M |
| March 31, 2014 | -379.44M |
| December 31, 2013 | -130.50M |
| September 30, 2013 | -143.04M |
| June 30, 2013 | -122.68M |
| March 31, 2013 | -61.87M |
| December 31, 2012 | 3.374M |
| September 30, 2012 | -19.36M |
| June 30, 2012 | -0.957M |
| March 31, 2012 | -5.921M |
| December 31, 2011 | 81.96M |
| September 30, 2011 | 108.75M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-558.48M
Minimum
Sep 2020
240.56M
Maximum
Mar 2023
-206.86M
Average
-273.30M
Median
Dec 2021
Cash from Investing (TTM) Benchmarks
| Ionis Pharmaceuticals Inc | -214.13M |
| Pfizer Inc | -32.28B |
| Blueprint Medicines Corp | 274.04M |
| Madrigal Pharmaceuticals Inc | -502.52M |
| Sarepta Therapeutics Inc | -165.80M |